Privo Technologies

Privo Technologies is a privately funded biotechnology company based in Peabody, Massachusetts. The company employs 11 people and has generated $2.5 million in revenue. Privo Technologies was founded by Manijeh Goldberg, a seasoned executive with over 25 years of experience in the medical industry. Privo Technologies is developing a novel nanotechnology-based drug delivery platform called the Mucosal Delivery Particle (MDP) platform. This platform is capable of local and systemic delivery of a constant, controlled therapeutic dose through the mucosa, eliminating the need for needles and avoiding stomach acids. The company's platform has applications for both small and large molecule drugs. Privo's technology has been recognized with awards and significant grants from the FDA and NIH. The company's founder, Manijeh Goldberg, holds an MBA from MIT and an MS from Harvard Medical School, and worked with Professor Robert Langer, a global expert in nanotechnology and drug delivery, who now serves as an advisor to Privo. For more information about Privo Technologies, please visit privotechnologies.com.